News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
307,231 Results
Type
Article (14664)
Company Profile (80)
Press Release (292475)
Multimedia
Podcasts (66)
Webinars (13)
Section
Business (110644)
Career Advice (351)
Deals (16435)
Drug Delivery (62)
Drug Development (34629)
Employer Resources (55)
FDA (5134)
Job Trends (6827)
News (152037)
Policy (10473)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (4)
2027 Pharm Country Standard (4)
Academia (1286)
Academic (1)
Accelerated approval (20)
ADA (25)
Adcomms (6)
Allergies (76)
Alliances (33705)
ALS (131)
Alzheimer's disease (1023)
Antibody-drug conjugate (ADC) (357)
Approvals (5479)
Artificial intelligence (619)
ASCO (156)
Autoimmune disease (221)
Automation (48)
Bankruptcy (145)
Best Places to Work (5860)
BIO (61)
BIOSECURE Act (11)
Biosimilars (130)
Biotechnology (62)
Bladder cancer (73)
Brain cancer (38)
Breast cancer (448)
Cancer (3423)
Cardiovascular disease (253)
Career advice (320)
Career pathing (26)
CAR-T (197)
CDC (16)
Celiac Disease (1)
Cell therapy (542)
Cervical cancer (26)
Clinical research (30607)
Collaboration (1951)
Company closure (3)
Compensation (383)
Complete response letters (40)
COVID-19 (1061)
CRISPR (76)
C-suite (853)
Cystic fibrosis (80)
Data (4146)
Decentralized trials (3)
Denatured (36)
Depression (93)
Dermatology (50)
Diabetes (305)
Diagnostics (3020)
Digital health (38)
Diversity (10)
Diversity, equity & inclusion (14)
Drug discovery (375)
Drug pricing (71)
Drug shortages (8)
Duchenne muscular dystrophy (155)
Earnings (32849)
Editorial (28)
Employer branding (4)
Employer resources (56)
Events (47301)
Executive appointments (739)
FDA (6997)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (12)
Frontotemporal dementia (21)
Funding (1444)
Gene editing (145)
Generative AI (61)
Gene therapy (440)
GLP-1 (515)
Government (1565)
Guidances (209)
Healthcare (8729)
Hematology (97)
HIV (60)
Huntington's disease (39)
IgA nephropathy (63)
Immunology and inflammation (184)
Immuno-oncology (83)
Indications (99)
Infectious disease (1240)
Inflammatory bowel disease (116)
Inflation Reduction Act (7)
Influenza (65)
Intellectual property (181)
Interviews (35)
IPO (7421)
IRA (17)
Job creations (1165)
Job search strategy (258)
JPM (39)
Kidney cancer (12)
Labor market (47)
Layoffs (197)
Leadership (20)
Legal (1926)
Liver cancer (42)
Longevity (22)
Lung cancer (455)
Lymphoma (259)
Machine learning (58)
Management (26)
Manufacturing (799)
Marketing (4)
MASH (102)
Medical device (4873)
Medtech (4944)
Mergers & acquisitions (9807)
Metabolic disorders (776)
mRNA (134)
Multiple sclerosis (104)
NASH (8)
Neurodegenerative disease (301)
Neuropsychiatric disorders (56)
Neuroscience (1965)
Neurotech (1)
NextGen: Class of 2026 (3187)
Non-profit (2533)
Now hiring (24)
Obesity (333)
Opinion (147)
Ovarian cancer (126)
Pain (125)
Pancreatic cancer (157)
Parkinson's disease (238)
Partnered (31)
Patents (309)
Patient recruitment (369)
Peanut (18)
People (29443)
Pharmaceutical (16)
Pharmacy benefit managers (8)
Phase 1 (10262)
Phase 2 (13476)
Phase 3 (9855)
Pipeline (5664)
Policy (117)
Postmarket research (612)
Preclinical (4468)
Press Release (52)
Prostate cancer (168)
Psychedelics (14)
Radiopharmaceuticals (208)
Rare diseases (605)
Real estate (2628)
Recruiting (23)
Regulatory (9577)
Reports (13)
Research institute (1413)
Resumes & cover letters (47)
Rett syndrome (25)
RNA editing (19)
RSV (32)
Schizophrenia (93)
Series A (286)
Series B (194)
Service/supplier (2)
Sickle cell disease (53)
Special edition (9)
Spinal muscular atrophy (103)
Sponsored (30)
Startups (2588)
Stomach cancer (6)
Supply chain (83)
Tariffs (36)
The Weekly (28)
Vaccines (533)
Venture capital (103)
Weight loss (190)
Women's health (78)
Worklife (4)
Date
Today (51)
Last 7 days (231)
Last 30 days (1049)
Last 365 days (15734)
2026 (9052)
2025 (15101)
2024 (17473)
2023 (20254)
2022 (23772)
2021 (27061)
2020 (25139)
2019 (22238)
2018 (16528)
2017 (14917)
2016 (13698)
2015 (16145)
2014 (11316)
2013 (8627)
2012 (9224)
2011 (9804)
2010 (8600)
Location
Africa (299)
Alabama (59)
Alaska (7)
Arizona (120)
Arkansas (9)
Asia (20513)
Australia (3322)
California (6986)
Canada (1917)
China (1069)
Colorado (294)
Connecticut (351)
Delaware (340)
Europe (47526)
Florida (935)
Georgia (205)
Hawaii (2)
Idaho (29)
Illinois (556)
India (60)
Indiana (442)
Iowa (10)
Japan (442)
Kansas (48)
Kentucky (25)
Louisiana (37)
Maine (66)
Maryland (977)
Massachusetts (5246)
Michigan (158)
Minnesota (320)
Mississippi (6)
Missouri (105)
Montana (27)
Nebraska (6)
Nevada (77)
New Hampshire (30)
New Jersey (1700)
New Mexico (23)
New York (1828)
North Carolina (865)
North Dakota (10)
Northern California (3703)
Ohio (190)
Oklahoma (16)
Oregon (18)
Pennsylvania (1206)
Puerto Rico (9)
Rhode Island (29)
South America (374)
South Carolina (39)
South Dakota (2)
Southern California (2618)
Tennessee (149)
Texas (1053)
United States (24539)
Utah (184)
Vermont (1)
Virginia (183)
Washington D.C. (23)
Washington State (545)
West Virginia (3)
Wisconsin (76)
Wyoming (2)
307,231 Results for "tetra discovery partners".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pelago Bioscience Acquires RG Discovery, Forming an Integrated Drug Discovery Partner Spanning Biology and Chemistry
June 15, 2026
·
3 min read
Press Releases
Axxam and HeartBeat.bio partner to advance human-relevant cardiovascular drug discovery and cardiac safety assessment
July 13, 2026
·
1 min read
Press Releases
Inocras and AimedBio Partner to Advance Cancer Drug Discovery and Precision Oncology with Whole Genome Intelligence
July 1, 2026
·
2 min read
Press Releases
Senzime to Showcase Expanded TetraGraph Capabilities with Launch of TetraAnalytics at Euroanaesthesia 2026
June 5, 2026
·
3 min read
Press Releases
Concept Life Sciences Partners with OpenBench to Deliver Success-Based Drug Discovery Services for Early-Stage Biotech
May 21, 2026
·
4 min read
Press Releases
Greenstone Biosciences, Inc. and Intel Corp. Launch Strategic Collaboration to Scale Human-Centric Drug Discovery.
Combining human iPSC biology and AI computing to accelerate drug discovery, improve drug safety, and advance precision medicine.
June 19, 2026
·
1 min read
Job Trends
Innovation Pressure Cooker: Tackling Drug Discovery’s Biggest Challenges
Drug discovery can be an uphill battle, especially lately given recent upheaval at the FDA and muted investment activity.
BioSpace
spoke to four industry executives about key issues facing those working in this space, starting with planning around uncertainty.
April 2, 2026
·
5 min read
·
Angela Gabriel
Press Releases
Chai Discovery Announces Collaboration with Novartis to Advance AI-Driven Antibody Discovery
July 13, 2026
·
2 min read
Approvals
Partner’s Bizengri cleared by FDA for ultra-rare cancer days after winning priority voucher
Partner Therapeutics announced last week that the FDA had granted Bizengri a Commissioner’s National Priority Voucher to accelerate drug review.
May 11, 2026
·
2 min read
·
Tristan Manalac
Artificial intelligence
Secretive AI drug hunter Xaira dips toe into dealmaking with hunt for partners
A mostly black box since emerging with more than a billion dollars in hand, Xaira Therapeutics is slowly pulling back the curtain, revealing plans to find partners and validate its pipeline.
July 8, 2026
·
3 min read
·
Annalee Armstrong
1 of 30,724
Next
